NEUMORA THERAPEUTICS INC (NMRA)
US6409791000 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -293.70M | -235.93M | -130.90M | -237.31M | -99.27M | |||
| Depreciation Amortization | 640.00K | 668.00K | 590.00K | 540.00K | 110.00K | |||
| Change In Working Capital | 10.88M | -8.90M | -6.95M | -960.00K | -3.12M | |||
| Other non cash items | 98.14M | 80.88M | 22.36M | 162.32M | 75.53M | |||
| OPERATING CASH FLOW | -184.04M | -163.28M | -114.90M | -75.42M | -26.76M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.41M | -4.71M | -13.51M | -820.00K | -1.30M | |||
| Other Investing Activity | 47.33M | 69.09M | -154.50M | 0.00 | -9.94M | |||
| INVESTING CASH FLOW | 41.92M | 64.39M | -168.01M | -820.00K | -11.24M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 55.91M | |||
| Stock Issued/Repurchased | 6.59M | 235.74M | 116.49M | 294.65M | 174.19M | |||
| Other Financing Activity | -1.04M | -3.80M | -740.00K | -1.14M | 0.00 | |||
| FINANCING CASH FLOW | 5.55M | 231.94M | 115.74M | 293.51M | 230.10M | |||
| CHANGE IN CASH | -136.57M | 133.05M | -167.17M | 217.27M | 192.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -184.04M | -163.28M | -114.90M | -75.42M | -26.76M | |||
| Capital Expenditure | -5.41M | -4.71M | -13.51M | -820.00K | -1.30M | |||
| FREE CASH FLOW | -189.45M | -167.99M | -128.41M | -76.24M | -28.06M | |||
All data in USD